Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04783857 · ClinicalTrials.gov registry record · Phase 4
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
A Phase 4 study of Smoking Cessation and Smoking, sponsored by University of Minnesota.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 279
- Enrollment target
- 1
- Study location
NCT04783857 is a Phase 4 study of Smoking Cessation and Smoking that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 279 participants, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04783857, a Phase 4 study of Smoking Cessation and Smoking, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 279 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators aim to address the following specific aims: * Determine the efficacy of Prog in preventing postpartum smoking relapse and reducing smoking relapse risk factors. * Examine the effects of this maternal smoking intervention on infant health. * Examine racial and ethnic differences in intervention outcomes.
Conditions Studied
Interventions
- DRUG Progesterone 200 MG Oral Capsule
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 279 participants |
| Start Date | 2022-04-14 |
| Est. Completion | 2026-06-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04783857
The ClinicalTrials.gov registry entry for NCT04783857 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 279 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (41% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which Progesterone 200 MG Oral Capsule is the first listed.
NCT04783857 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04783857 about?
NCT04783857 is a clinical study titled "Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children". The investigators aim to address the following specific aims: * Determine the efficacy of Prog in preventing postpartum smoking relapse and reducing smoking relapse risk factors. * Examine the effects of this maternal smoking intervention on infant health. * Examine racial and ethnic differences in...
What is the current status of trial NCT04783857?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 279 participants. The study started on 2022-04-14. Estimated completion is 2026-06-02.
What conditions does trial NCT04783857 study?
This clinical trial studies the following conditions: Smoking Cessation, Smoking, Smoking Reduction.
What interventions are being tested in trial NCT04783857?
The interventions under investigation include: Progesterone 200 MG Oral Capsule (DRUG).
Who is sponsoring clinical trial NCT04783857?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04783857 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Options 2 Study
RECRUITING · Phase 4
-
Smoking Cessation Program in the Construction Sector
RECRUITING · Phase 4
-
The Avenues Study: Dual Use Cessation
RECRUITING · Phase 4
-
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
RECRUITING · Phase 4
-
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
ACTIVE NOT RECRUITING · Phase 4
-
Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.